Boehringer Ingelheim Inks $500M+ Deal with Sitryx Therapeutics for Novel Oral Immune Disease Therapies
Shots: Ref: Sitryx | Image: Sitryx & BI | Press Release Related News: Frontier Biotechnologies and GSK Forge ~$1B Global…
Read article →
Post-Conference Highlights | 2026 ViVE | Feb 22–25 | Los Angeles, CA
ViVE 2026 in Los Angeles convened policymakers, health system executives, payers, technologists, investors, and founders…
Read article →
Cara Medical Reports 510(k) clearance of CARA System for Noninvasive Cardiac Conduction System Visualization
Shots: Ref: PRnewswire | Image: Cara Medical | Press Release Related News: VB Spine to Acquire Exclusive Rights to…
Read article →
GSK Reports the NMPA’s NDA Acceptance with Priority Review of Linerixibat for Cholestatic Pruritus
Shots: Ref: GSK | Image: GSK | Press Release Related News: GSK to Acquire 35Pharma for $950M PharmaShots, your go-to…
Read article →
Merck Animal Health’s Numelvi Secures the FDA Approval for Control of Pruritus Associated with Allergic Dermatitis in Dogs
Shots: Ref: Businesswire | Image: Merck Animal Health | Press Release Related News: Merck Animal Health’s Exzolt…
Read article →
ViiV Healthcare Reports P-IIb (EMBRACE) Trial Data on Lotivibart + Cabotegravir for HIV Treatment
Shots: Ref: GSK | Image: ViiV | Press Release Related News: ViiV Healthcare Reports P-III (LATITUDE) Trial of Cabenuva…
Read article →
argenx Reports Topline P-III (ADAPT OCULUS) Trial Data on Vyvgart in Ocular Myasthenia Gravis (MG)
Shots: Ref: argenx | Image: argenx | Press Release Related News: argenx Receives Health Canada’s Approval for Vyvgart SC…
Read article →
Novo Nordisk and Vivtex Partner in ~2.1B Metabolic Deal to Develop Oral Therapies
Shots: Ref: Novo Nordisk | Image: Novo Nordisk & Vivtex | Press Release Related News: Novo Nordisk Reports EC Approval…
Read article →